Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial ...

Please provide your email address to receive an email when new articles are posted on . Delayed presentation of 24 hours or more after non-STEMI symptom onset was associated with greater risk for ...